Literature DB >> 2566281

A novel effect of norepinephrine on cardiac cells is mediated by alpha 1-adrenoceptors.

D Fedida1, Y Shimoni, W R Giles.   

Abstract

In the heart, alpha-adrenergic agonists have long been known to produce a positive inotropic effect that is rate dependent and associated with action potential prolongation but is not accompanied by adenosine 3',5'-cyclic monophosphate (cAMP) elevation. The ionic mechanism of these effects is unknown. We report that a transient outward K+ current, a major determinant of plateau duration in rabbit and human atria, is strongly inhibited by norepinephrine and the alpha-adrenoceptor agonists methoxamine and phenylephrine. These effects of alpha-stimulation can be blocked by prazosin. The reduction in the transient outward current substantially slows action potential repolarization. These results can explain the regional and species-dependent positive inotropic effects of alpha-adrenergic stimulation in the heart and give important new insight into the autonomic regulation of cardiac function. In addition, reduction in this repolarizing current during the enhanced alpha-adrenergic responsiveness of myocardial ischemia may be a factor in the genesis of arrhythmias produced by catecholamines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566281     DOI: 10.1152/ajpheart.1989.256.5.H1500

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  Actions and mechanisms of action of novel analogues of sotalol on guinea-pig and rabbit ventricular cells.

Authors:  S P Connors; E W Gill; D A Terrar
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Alpha 1-adrenoceptors reduce background K+ current in rabbit ventricular myocytes.

Authors:  D Fedida; A P Braun; W R Giles
Journal:  J Physiol       Date:  1991-09       Impact factor: 5.182

3.  The calcium antagonist D600 inhibits calcium-independent transient outward current in isolated rat ventricular myocytes.

Authors:  I A Lefevre; A Coulombe; E Coraboeuf
Journal:  J Physiol       Date:  1991-01       Impact factor: 5.182

4.  Potent inhibitory action of chlorethylclonidine on the positive inotropic effect and phosphoinositide hydrolysis mediated via myocardial alpha 1-adrenoceptors in the rabbit ventricular myocardium.

Authors:  M Takanashi; I Norota; M Endoh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

5.  Modulation of the inwardly rectifying K+ channel in isolated human atrial myocytes by alpha 1-adrenergic stimulation.

Authors:  R Sato; S Koumi
Journal:  J Membr Biol       Date:  1995-11       Impact factor: 1.843

6.  Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.

Authors:  H Nakaya; N Tohse; Y Takeda; M Kanno
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

7.  Induction by endogenous noradrenaline of an alpha 1-adrenoceptor-mediated positive inotropic effect in rabbit papillary muscles.

Authors:  Y Hattori; Y Takeda; H Nakaya; M Kanno
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  Role of alpha 1A adrenoceptor subtype in production of the positive inotropic effect mediated via myocardial alpha 1 adrenoceptors in the rabbit papillary muscle: influence of selective alpha 1A subtype antagonists WB 4101 and 5-methylurapidil.

Authors:  M Endoh; M Takanashi; I Norota
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

9.  Depolarization-induced influx of sodium in response to phenylephrine in rat atrial heart muscle.

Authors:  U Jahnel; H Nawrath; E Carmeliet; J Vereecke
Journal:  J Physiol       Date:  1991-01       Impact factor: 5.182

Review 10.  Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance.

Authors:  Timothy D O'Connell; Brian C Jensen; Anthony J Baker; Paul C Simpson
Journal:  Pharmacol Rev       Date:  2013-12-24       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.